Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

InsideArbitrage Potential Deal Alert: Amedisys (AMED) Announces Receipt of Unsolicited Proposal From Optum

  • June 5, 2023


Stock Amedisys, Inc. Symbol AMED
Date Announced 06/05/2023 Source Press Release
Type Unsolicited Bid Acquiring Company/Person UnitedHealth Group Incorporated
Date of Confirmation: 06/26/2023 Price at Confirmation: $90.92
Potential Profit: -0.89% Annualized Profit: -15.54%

Amedisys (AMED) announced that on May 26, 2023, the company received an unsolicited proposal from Optum, a diversified health services company, to acquire all of the outstanding shares of Amedisys’ common stock in an all-cash transaction for $100 per share.

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.